<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-147595</identifier>
<setSpec>1135-8831</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Exposure to pulmonary tuberculosis in a neonatal unit: diagnostic and therapeutic decisions</dc:title>
<dc:description xml:lang="en">Background. Neonates have an increased risk to suffer severe tuber culosis due to their immunosuppressed condition. Objective. To assess the incidence of tuberculosis infection or latent disease in a cohort of newborns exposed to a healthcare worker of the neonatal unit, diagnosed with pulmonary tuberculosis disease, as well as describe diagnostic and treatment strategies. Method. Tuberculin skin test (TST) and chest X-rays were performed at the initial screening. Chest computed tomography (CT) and QuantiFERON®-TB Gold test were performed on cases where chest X-ray was not clear. Once all diagnostic tests were negative, infants were treated with isoniazid up to 6 months of age. At this age, a second TST was performed. Results. 60 newborns were exposed. TST were negative at baseline and at 6 months. One infant had an abnormal chest X-ray, with normal findings on CT and QuantiFERON®-TB Gold test. 88.6% neonates started with prophylaxis, it was contraindicated in 3% and was refused by the parents in 8%. Isoniazid was withdrawn due to side effects in only 1 infant. Prophylaxis was completed by 78% of patients. At 12 months, no cases of tuberculosis were reported. Conclusions. The tuberculous infection incidence in hospitalized neonates exposed is low but, due to the potential severity, prophylaxis with isoniazid until 6 months and an early screening with TST and chest X-ray is a valid strategy to minimized risks (AU)</dc:description>
<dc:creator>Marcos, José Ángel de</dc:creator>
<dc:creator>Olmo, Montse</dc:creator>
<dc:creator>Font, Roser</dc:creator>
<dc:creator>Mirada, Alicia</dc:creator>
<dc:creator>Canales, Lidia</dc:creator>
<dc:creator>Mur, Antonio</dc:creator>
<dc:creator>Molera, Cristina</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento. Los neonatos tienen un riesgo incrementado de sufrir enfermedad tuberculosa grave dada su condición de inmunosupresión. Objetivo. Evaluar la incidencia de infección tuberculosa o enfermedad latente en una cohorte de neonatos expuestos a un trabajador sanitario de una unidad neonatal diagnosticado de enfermedad tuberculosa pulmonar, así como describir las estrategias para su diagnóstico y tratamiento. Método. Para el cribado inicial se realizó una prueba de tuberculina (PT) yuna radiografía (Rx) torácica. En caso de duda, se practicaría tomografía axial computerizada (TC) y prueba del QuantiFERON®-TB Gold test. Descartada la infección, se inició tratamiento con isoniazida hasta los 6 meses. A esta edad se practicó una segunda PT. Resultados. Sesenta neonatos fueron expuestos. La PT fue negativa tanto al inicio como a los 6 meses. Un neonato presentaba una imagen dudosa en la radiografía torácica, pero la TC y el QuantiFERON®-TB Gold test fueron normales. El 88,6% de los neonatos iniciaron profilaxis, se contraindicó en el 3% y hubo negativa de los padres en el 8%. Tan sólo un paciente presentó efectos secundarios por isoniazida. El 78% de los casos completó la profilaxis. A los 12 meses no se detectó ningún caso de tuberculosis. Conclusiones. La incidencia de infección tuberculosa en neonatos hospitalizados expuestos es baja, pero, debido a la potencial gravedad, la profilaxis con isoniazida hasta los 6 meses y un cribado precoz con una PT y una Rx torácica pueden ser una estrategia válida para minimizar el riesgo (AU)</dc:description>
<dc:source>Pediatr. catalan;75(4): 158-162, oct.-dic. 2015. tab, ilus</dc:source>
<dc:identifier>ibc-147595</dc:identifier>
<dc:title xml:lang="es">Exposición a tuberculosis pulmonar en una unidad neonatal: decisiones diagnósticas y terapéuticas</dc:title>
<dc:subject>^d24375^s22045</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d3181^s37748</dc:subject>
<dc:subject>^d14798^s22013</dc:subject>
<dc:subject>^d1255^s22061</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23106^s22000</dc:subject>
<dc:subject>^d23106^s22044</dc:subject>
<dc:subject>^d14190^s22011</dc:subject>
<dc:subject>^d14190^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d3181^s22011</dc:subject>
<dc:subject>^d3181^s22056</dc:subject>
<dc:subject>^d24375^s22039</dc:subject>
<dc:subject>^d35251</dc:subject>
<dc:subject>^d1255^s22044</dc:subject>
<dc:subject>^d1255^s22033</dc:subject>
<dc:subject>^d14798^s22053</dc:subject>
<dc:subject>^d22226</dc:subject>
<dc:subject>^d14798^s22044</dc:subject>
<dc:subject>^d3181^s22019</dc:subject>
<dc:subject>^d14798^s22033</dc:subject>
<dc:subject>^d1255^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>201512</dc:date>
</metadata>
</record>
</ibecs-document>
